# Substrate Modification in Stable Ventricular Tachycardia in Addition to Implantable Cardioverter Defibrillator (ICD) Therapy

> **NCT00919373** · NA · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 110 (actual)

## Conditions studied

- Ventricular Tachycardia
- Coronary Artery Disease
- Left Ventricular Dysfunction

## Interventions

- **PROCEDURE:** Substrate modification
- **PROCEDURE:** VT ablation
- **PROCEDURE:** ICD Implantation

## Key facts

- **NCT ID:** NCT00919373
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-07
- **Primary completion:** 2006-01
- **Final completion:** 2006-01
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2019-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00919373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00919373, "Substrate Modification in Stable Ventricular Tachycardia in Addition to Implantable Cardioverter Defibrillator (ICD) Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00919373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*